Transfer factor and methods of use

Details Transfer factor and methods of use Transfer factor and methods of use

1994-07-22

1995-11-28

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530344, 530417, 530300, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

054708354

ABSTRACT:
The invention relates to substantially pure transfer factor with a specific activity of at least 5000 units per absorbance unit at 214 nm. The present invention also relates to a process for preparing the transfer factor from cell lysates. The present invention includes the use of substantially pure transfer factor with a specific activity of at least 5000 units per absorbance unit at 214 nm to treat infectious diseases.

REFERENCES:
patent: 3991182 (1974-11-01), Spitler et al.
patent: 4001080 (1977-01-01), Goust et al.
patent: 4132776 (1979-01-01), Jeter
patent: 4289690 (1981-09-01), Pestra et al.
patent: 4435384 (1984-03-01), Warren
patent: 4468379 (1984-08-01), Gottlieb
patent: 4616079 (1986-10-01), Gottlieb
patent: 4816563 (1989-03-01), Wilson et al.
Kirkpatrick, J. Immun. vol. 134(3): 1723-27 (Mar. 1985).
Vandenbark et al. J. Immun. vol. 118 No. 2 (Feb. 1977).
Kirkpatrick et al. J. Immun. vol. 135 (6) (Dec. 1985).
Borkowsky, J. Immun. vol. 120(2) 480-489 (1981).
Super et al. Biotechniques Nov./Dec. 1983 198-203.
Lawrence et al. Cell Immun vol. 82 102-16 (1983).
Kirkpatrick, "Transfer Factor: Perspectives In Human and Veterinary Medicine," J. Exp. Path., vol. 3, No. 4, pp. 383-398 (1987).
Kirkpatrick, et al., "Transfer Factor: Progress Toward Isolation And Chemical Characterization," The Lympokines, pp. 261-274 (The Humana Press 1981).
Petersen, et al., "Selective Removal of Transfer Factor Activity With Antigen," Immunobiology of Transfer Factor, ed. Kirkpatrick, pp. 65-74 (Academic Press, 1983).
Borkowsky, et al., "Deletion Of Antigen-Specific Activity from Leukocyte Dialysates Containing Transfer Factor By Antigen-Coated Polystyrene," J. Immunol., vol. 126, No. 2, pp. 486-489 (1981).
Peterson, et al., "Murine Transfer Factor: I. Description of the Model and Evidence for Specificity," J. Immunol., vol. 126, No. 6, pp. 2480-2484 (1981).
Kirkpatrick, et al., "Murine Transfer Factor: II. Transfer of Delayed Hypersensitivity to Synthetic Antigens," J. Immunol., vol. 134, No. 3, pp. 1723-1727 (1985).
Kirkpatrick, et al., "Murine Transfer Factor: III. Specific Interactions Between Transfer Factor and Antigen," J. Immunol., vol. 135, No. 6, pp. 4027-4033 (1985).
Huang, et al., "Nature and Antigen-Specific Activities of Transfer Factor Against Herpes Simplex Virus Type 1.," Acta Virol., vol. 31, pp. 449-457 (1987).
Kirkpatrick et al. J. Immuno. vol. 135 No. 6 (Dec. 1985) 402.7.
Peterson et al. J. Immun. vol. 126 No. 6 (Jun. 1981) 2480.
Burger, et al., "Human Transfer Factor: Structural Properties Suggested By HPRP Chromatography and Enzymatic Sensitivities," J. Immunol., vol. 122, No. 3, pp. 1091-1098 (1979).
Rozzo, et al., "Murine Transfer Factor IV. Studies with Genetically Regulated Immune Responses," Cell. Immunol., vol. 115, pp. 130-145 (1988).
Lawrence, et al., "A New Basis for the Immunoregulatory Activities of Transfer Factor--An Arcane Dialect in the Language of Cells," Cell. Immunol., vol. 82, pp. 102-116 (1983).
Borkowsky, et al., "Antigen-Specific Suppressor Factor in human Leukocyte Dialysates: A Product of Ts Cells Which Bind to Anti-V Region and Anti-Ia Region Antibodies," Immunobiology of Transfer Factor, ed. Kirkpatrick, pp. 91-115 (Academic Press, 1983).
Vandenbark, et al., "Human Transfer Factor: Fractionation By Electrofocusing and High Pressure, Reverse Phase Chromatography," J. Immunol., vol. 118, No. 2, pp. 636-641 (1977).
Wilson, et al., "The Chemical Nature of the Antigen-Specific Moiety of Transfer Factor", Chemical Structure of Transfer Factor, Publication No. 295, Dept. of Basic and Clinical Immunology and Microbiology, Medical University of South Carolina, pp. 239-256.
Sinha, et al., "Immunomodulatory Components Present in IMREG-1, an Experimental Immunosupportive Biologic", Bio/Technology, vol. 6, pp. 810-815 (1988).
Lawrence, et al., "Transfer of Immunologic Information in Humans with Dialysates of Leukocyte Extracts", Department of Medicine, New York University School of Medicine, pp. 84-89.
Kirkpatrick, "Transfer Factor", Allergy Clin. Immunol., vol. 81, No. 5, pp. 803-813 (1988).
Steele, et al., "Transfer Factor for the Prevention of Varicella-Zoster Infection in Childhood Leukemia", N. Engl. J. Med., vol. 303, No. 7, pp. 355-359 (1980).
Dwyer, "The Use of Antigen Specific Transfer Factor in the Management of Infection with Herpes Viruses", Immunobiology of Transfer Factor, Academic Press, New York, pp. 233-243 (1983).
Viza, et al., "Orally Administered Specific Transfer Factor for the Treatment of Herpes Infections", Lymphokine Res., vol. 4, No. 1, pp. 27-30 (1985).
McMeeking, et al., "A Controlled Trial of Bovine Dialyzable Leukocyte Extract for Cryptosporidiosis in Patients with AIDS", J. Infect. Dis., vol. 161, pp. 108-112 (1990).
Kirkpatrick, et al., "Treatment of Chronic Mucocutaneous Candidiasis with Transfer Factor", Immune Regulators in Transfer Factor, Academic Press, New York, pp. 547-562 (1979).

Affiliated with

Also associated with

Rating

Transfer factor and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transfer factor and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transfer factor and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2013728